Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:973808.
doi: 10.4061/2011/973808. Epub 2011 Sep 29.

Lambert-eaton myasthenic syndrome; pathogenesis, diagnosis, and therapy

Nils Erik Gilhus  1
Affiliations

Lambert-eaton myasthenic syndrome; pathogenesis, diagnosis, and therapy

Nils Erik Gilhus. Autoimmune Dis. 2011.

Abstract

Lambert-Eaton Myasthenic Syndrome (LEMS) is a rare disease with a well-characterized pathogenesis. In 50% of the patients, LEMS is a paraneoplastic manifestation and caused by a small cell lung carcinoma (SCLC). Both LEMS patients with SCLC and those without this tumour have in 85% of cases pathogenetic antibodies of very high LEMS specificity against voltage-gated calcium channels (VGCCs) in the cell membrane of the presynaptic motor nerve terminal. Better understanding of LEMS pathogenesis has lead to targeted symptomatic therapy aimed at the neuromuscular junction and to semispecific immuno-suppression. For SCLC LEMS, tumour therapy is essential.

PubMed Disclaimer

References

    1. Lambert EH, Eaton LM, Rooke ED. Defect of neuromuscular conduction associated with malignant neoplasms. American Journal of Physiology. 1956;187:612–613.
    1. Wirtz PW, Nijnuis MG, Sotodeh M, et al. The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland. Journal of Neurology. 2003;250(6):698–701. - PubMed
    1. Titulaer MJ, Verschuuren JJGM. Lambert-Eaton myasthenic syndrome: tumor versus nontumor forms. Annals of the New York Academy of Sciences. 2008;1132:129–134. - PubMed
    1. Lorenzoni PJ, Scola RH, Kay CSK, Parolin SF, Werneck LC. Non-paraneoplastic Lambert-Eaton myasthenic syndrome. Arq Neuropsiquiatr. 2010;68(6):849–854. - PubMed
    1. Elrington GM, Murray NMF, Spiro SG, Newsom-Davis J. Neurological paraneoplastic syndromes in patients with small cell lung cancer. Journal of Neurology Neurosurgery and Psychiatry. 1991;54(9):764–767. - PMC - PubMed

LinkOut - more resources